Food changes the early pharmacokinetic profile of oral sildenafil mainly by slowing absorption. For conventional sildenafil tablets, current U.S. labeling reports that a high-fat meal delays mean Tmax by approximately 60 minutes and reduces mean Cmax by approximately 29% compared with fasting conditions.
The effect on total exposure is smaller than the effect on the peak. In a controlled 100 mg tablet food-effect study, mean sildenafil AUC was approximately 11% lower under fed conditions, while Cmax was approximately 29% lower and mean Tmax shifted from about 0.95 hour fasting to about 2.04 hours fed.
Food effects are also formulation-specific. Current VYBRIQUE oral-film labeling reports a mean Tmax delay of 87 minutes and a 45% reduction in Cmax after a high-fat meal, while AUC was not affected. This page therefore focuses on measured PK changes rather than assuming that every sildenafil formulation, meal or individual response follows one universal food-effect pattern.
A sildenafil food effect is a measurable difference in pharmacokinetics when a product is administered under fed conditions instead of fasting conditions. Researchers commonly compare the resulting concentration-time profiles using Tmax, Cmax and AUC.
For conventional sildenafil tablets, the best-established pattern is slower absorption after a high-fat meal: peak concentration occurs later and the peak itself is lower. The reduction in integrated exposure is substantially smaller than the reduction in Cmax.
This distinction is important because 'food effect' does not mean one uniform percentage change in sildenafil exposure. Rate of absorption, peak magnitude and total systemic exposure are separate PK properties and should be interpreted separately within the broader sildenafil pharmacokinetic framework.
| Food-Effect Question | Relevant PK Measure | Conventional Tablet Finding |
|---|---|---|
| Does the concentration peak occur later? | Tmax | Mean delay approximately 60 minutes with a high-fat meal |
| Does peak concentration change? | Cmax | Mean reduction approximately 29% |
| Does total systemic exposure change? | AUC | Approximately 11% lower in the dedicated 100 mg food-effect study |
| Does the early curve change? | Absorption profile | Slower systemic appearance under fed conditions |
After an oral sildenafil product is administered, the dosage form must release sildenafil and the drug must move through the gastrointestinal tract before reaching the principal sites of absorption. A meal can change this early sequence by altering gastric emptying and other gastrointestinal conditions.
The classic sildenafil food-effect data are consistent with slower systemic input after a high-fat meal. In the 100 mg tablet study, mean Tmax moved from approximately 0.95 hour in the fasting state to approximately 2.04 hours after the standardized high-fat meal.
That later peak is primarily a rate-of-absorption effect. It should not be interpreted as proof that the same proportion of the dose has failed to enter systemic circulation. The underlying pre-systemic processes are covered in greater depth on the sildenafil absorption page.
| GI / PK Feature | Food-Effect Interpretation |
|---|---|
| Gastric emptying | A high-fat meal can delay delivery of sildenafil to downstream absorptive regions. |
| Systemic appearance | Concentrations rise more slowly under fed conditions. |
| Tmax | Peak occurs later. |
| Cmax | Peak can become lower because systemic input is spread over more time. |
High-fat, high-calorie meal conditions are used in formal food-effect research because they create a standardized fed state capable of revealing clinically relevant changes in oral-drug absorption. They should not be treated as equivalent to every breakfast, snack or ordinary meal.
In the dedicated sildenafil study, 34 healthy male subjects received a single 100 mg tablet under fasting conditions and after a standardized high-fat breakfast in a randomized crossover design. The meal contained approximately 68 g of fat and about 4,092 kJ of energy, roughly 980 kcal.
Under those conditions, sildenafil Cmax was approximately 71% of the fasting value, corresponding to a 29% reduction; mean Tmax was delayed by about 1.1 hours; and AUC was approximately 89% of the fasting value, corresponding to an 11% reduction in total systemic exposure.
| 100 mg Tablet Food-Effect Study | Fasted | Fed |
|---|---|---|
| Mean / geometric mean Cmax | 514 ng/mL | 364 ng/mL |
| Mean Tmax | Approximately 0.95 h | Approximately 2.04 h |
| Mean / geometric mean AUC | 1670 ng·h/mL | 1489 ng·h/mL |
| Fed : fasted Cmax ratio | Reference | 0.71 |
| Fed : fasted AUC ratio | Reference | 0.89 |
Tmax describes the time at which the highest sampled sildenafil concentration occurs. For conventional tablets, current U.S. labeling reports a mean Tmax delay of approximately 60 minutes when sildenafil is taken with a high-fat meal.
The dedicated 100 mg crossover study provides the underlying scale more directly: mean Tmax was approximately 0.95 hour in fasting subjects and approximately 2.04 hours after the standardized high-fat meal.
A later Tmax establishes delayed peak concentration, not an equivalent delay in every pharmacodynamic event. Sildenafil-related effects can begin before Cmax is reached, so peak timing remains distinct from the clinical onset question addressed on the sildenafil Tmax page and sildenafil onset page.
| Tmax Observation | Interpretation |
|---|---|
| Fasted conventional tablet | Peak concentrations typically occur within 30–120 minutes; median about 60 minutes in current labeling. |
| High-fat meal | Mean Tmax delayed approximately 60 minutes. |
| Dedicated 100 mg study | Mean Tmax approximately 0.95 h fasted vs 2.04 h fed. |
| Clinical onset | Cannot be calculated directly from Tmax. |
Cmax is the highest observed sildenafil plasma concentration in the sampled profile. Slower absorption after a high-fat meal produces a flatter concentration curve and lowers the peak reached at any one time.
Current conventional-tablet labeling reports a mean Cmax reduction of approximately 29%. In the dedicated food-effect study, geometric mean Cmax decreased from approximately 514 ng/mL in the fasting condition to approximately 364 ng/mL after the high-fat meal.
The 29% reduction in peak concentration should not be converted into a 29% reduction in total exposure or clinical response. Cmax is a peak metric; the corresponding AUC reduction in that study was much smaller. Peak-specific interpretation remains on the sildenafil Cmax page.
| Cmax Measure | Finding |
|---|---|
| Fasted 100 mg study | Approximately 514 ng/mL |
| Fed 100 mg study | Approximately 364 ng/mL |
| Fed : fasted ratio | 0.71 |
| Approximate reduction | 29% |
AUC measures integrated sildenafil exposure across the complete concentration-time profile and therefore answers a different question from Cmax. A high-fat meal can lower and delay the peak without reducing the total area by the same proportion.
In the dedicated 100 mg tablet food-effect study, mean sildenafil AUC was approximately 1,670 ng·h/mL fasting and 1,489 ng·h/mL fed. The fed-to-fasted ratio was 0.89, corresponding to an approximately 11% reduction in systemic exposure.
The study authors characterized the food-related changes in sildenafil exposure as small, but the exact clinical interpretation of PK differences should not be generalized to every person or formulation. Detailed AUC interpretation remains on the sildenafil AUC page, while the complete integrated framework is covered on the sildenafil exposure page.
| Exposure Metric | Fasted | Fed | Food Effect |
|---|---|---|---|
| AUC | 1670 ng·h/mL | 1489 ng·h/mL | Approximately -11% |
| Cmax | 514 ng/mL | 364 ng/mL | Approximately -29% |
| Tmax | Approximately 0.95 h | Approximately 2.04 h | Approximately +1.1 h |
The main visual consequence of food is a redistribution of early sildenafil exposure across time. Under fasting conditions the concentration curve rises more steeply and reaches a higher peak sooner; after a high-fat meal the early curve rises more slowly, reaches a lower peak and shifts to the right.
For conventional tablets, this pattern is summarized by Cmax approximately 29% lower, Tmax delayed roughly 1 hour and AUC only about 11% lower in the dedicated study. The fed curve is therefore delayed and flattened rather than simply scaled downward uniformly.
Formulation also matters. Current VYBRIQUE oral-film labeling reports a different quantitative profile after a high-fat meal: mean Tmax delayed 87 minutes, Cmax reduced 45% and AUC not affected. The mechanics of comparing complete curves remain on the sildenafil concentration-time page.
| Current Product Context | Tmax Food Effect | Cmax Food Effect | AUC Food Effect |
|---|---|---|---|
| Conventional sildenafil tablet | Mean delay about 60 min | Mean reduction about 29% | About 11% lower in the dedicated 100 mg tablet study |
| VYBRIQUE oral film | Mean delay about 87 min | Mean reduction about 45% | Not impacted by food in current labeling |
The phrase 'taken with food' can describe many different physiological conditions. A small snack, a low-fat meal and a standardized high-fat, high-calorie breakfast should not automatically be expected to produce identical sildenafil pharmacokinetic effects.
The classic sildenafil food-effect study used a deliberately substantial meal containing approximately 68 g fat, 50 g protein and 45 g carbohydrate, with total energy of about 4,092 kJ. The measured 29% Cmax reduction and 11% AUC reduction therefore belong to that controlled fed condition.
This is why the safest scientific wording refers specifically to a high-fat meal rather than claiming that every meal delays sildenafil by exactly one hour. Meal composition is part of the experimental condition and should remain attached to the PK result.
| Meal Characteristic | Classic Sildenafil Study Condition |
|---|---|
| Fat | Approximately 67.9 g |
| Protein | Approximately 49.9 g |
| Carbohydrate | Approximately 44.8 g |
| Energy | Approximately 4,092 kJ (~980 kcal) |
| Interpretation | Standardized high-fat research meal, not every possible fed condition |
The dedicated sildenafil food-effect study used a randomized two-period crossover design in 34 healthy male subjects. Each participant received a single 100 mg sildenafil tablet under both fasting and fed conditions, with the order randomized and the study periods separated by a washout.
Serial plasma samples were collected so investigators could compare the complete concentration-time profiles. Cmax, Tmax and AUC were then evaluated between fed and fasting treatments instead of relying on one plasma sample.
A crossover design is useful because each participant contributes data under both meal conditions, reducing some of the between-person variability that would otherwise complicate the food-effect comparison.
| Study Element | Sildenafil Food-Effect Study |
|---|---|
| Participants | 34 healthy male subjects |
| Design | Randomized two-way crossover |
| Dose | Single oral 100 mg sildenafil tablet |
| Conditions | Fasted vs standardized high-fat meal |
| Primary PK comparisons | AUC, Cmax and Tmax |
Food affects the rate of sildenafil absorption more strongly than the overall extent of systemic exposure in the conventional-tablet study. Cmax fell approximately 29%, whereas AUC fell approximately 11%.
In that study, the fed-to-fasted AUC ratio was 0.89, which can also be described as relative systemic availability of approximately 89% under the tested high-fat condition compared with fasting. This is different from sildenafil's absolute oral bioavailability, which is approximately 41% relative to intravenous administration.
Keeping these definitions separate prevents an important error: a high-fat-meal food-effect ratio should not be confused with the absolute fraction of an oral sildenafil dose reaching circulation. The broader systemic-availability concept remains on the sildenafil bioavailability page.
| Concept | Sildenafil Value / Meaning |
|---|---|
| Absolute oral bioavailability | Mean approximately 41% relative to intravenous sildenafil |
| Fed : fasted AUC ratio in 100 mg food study | Approximately 0.89 |
| Relative fed-state exposure | Approximately 89% of the fasting AUC in that study |
| Same concept? | No; absolute and fed-versus-fasted relative bioavailability answer different questions |
Meal state can produce within-person and between-study differences in sildenafil PK even when the nominal dose is identical. A fasting measurement cannot be assumed to reproduce the same Cmax or Tmax observed after a substantial meal.
Meal composition adds further variability because the controlled high-fat research condition is more standardized than everyday eating. Differences in fat content, total calories, meal timing and formulation can all alter the early systemic-input pattern.
The newer VYBRIQUE food-effect data demonstrate why formulation belongs in this variability framework: its high-fat meal effect on Cmax and Tmax differs quantitatively from the conventional tablet profile. Broader PK variability is discussed on the sildenafil PK variability page.
| Variable | Potential PK Effect |
|---|---|
| Fasted vs fed state | Changes early absorption profile. |
| Meal composition | Can change magnitude of the food effect. |
| Meal timing | Can influence gastrointestinal conditions at administration. |
| Dosage form | Can produce a different quantitative food-effect profile. |
| Individual physiology | Adds variability around average study findings. |
A high-fat meal delays the sildenafil plasma peak, but Tmax is not the same metric as onset of pharmacodynamic response. A biological effect can begin while plasma concentration is still rising and before Cmax has been reached.
Current conventional-tablet patient labeling nevertheless acknowledges the practical direction of the food effect by stating that sildenafil may take a little longer to start working after a high-fat meal. That counseling statement is compatible with slower absorption but does not establish that every individual experiences exactly a 60-minute onset delay.
The key distinction is therefore between population-level pharmacokinetics and individual clinical timing: mean Tmax shifts can support a general expectation of slower onset under high-fat conditions without functioning as a precise personal clock. The onset framework remains on the sildenafil onset page.
| Concept | What the Evidence Supports |
|---|---|
| Tmax +60 min | Mean plasma peak occurs later for conventional tablets after a high-fat meal. |
| Patient-label wording | High-fat food may make sildenafil take somewhat longer to start working. |
| Exactly +60 min clinical onset for everyone | Not established. |
| Onset | Pharmacodynamic / clinical timing rather than peak-concentration timing. |
The measured food effects are pharmacokinetic observations. A 29% reduction in Cmax or an 11% reduction in AUC does not mean that erectile response, effectiveness or duration changes by the same percentage.
The original 100 mg food-effect investigators considered the observed PK changes small in clinical terms, but that population-level interpretation should not be transformed into a guarantee of identical individual experience under fed and fasting conditions.
Clinical response depends on the exposure-response relationship, stimulation and individual pharmacodynamics after systemic sildenafil becomes available. That concentration-to-effect relationship remains on the sildenafil pharmacodynamics page.
| Measured Finding | What It Establishes | What It Does Not Establish |
|---|---|---|
| Cmax -29% | Lower conventional-tablet plasma peak after the studied high-fat meal | 29% lower clinical response |
| AUC -11% | Slightly lower integrated exposure in the 100 mg study | 11% shorter effect duration |
| Tmax +~1 h | Later mean peak concentration | Exactly one-hour later onset for every individual |
Food-effect experiments characterize what meal conditions do to sildenafil pharmacokinetics. They do not provide a mathematical basis for changing the amount of sildenafil administered to compensate for a lower Cmax or delayed Tmax.
For example, a 29% reduction in conventional-tablet Cmax after a high-fat meal does not imply that dose should be increased by 29%. Dose, safety, drug interactions and clinical response are separate prescribing considerations.
Formulation differences make simple compensation even less defensible: VYBRIQUE shows a larger high-fat-meal Cmax reduction than conventional tablets while its AUC is reported as unaffected by food. General label-based dosing information remains on the sildenafil dosage page.
| Question | Relevant Domain |
|---|---|
| How does food change sildenafil Cmax, Tmax or AUC? | Food-effect pharmacokinetics |
| Should the dose be mathematically adjusted for food? | Not established by food-effect PK data |
| Which dosage is appropriate? | Product labeling and clinical prescribing context |
| Can food effects differ by formulation? | Yes |
For conventional sildenafil tablets, the clearest quantitative summary is that a high-fat meal primarily slows absorption: mean Tmax is delayed by about 60 minutes and mean Cmax falls by about 29%. The dedicated 100 mg study found a smaller reduction in AUC of approximately 11%.
The profile should not be generalized blindly across formulations. Current VYBRIQUE oral-film labeling reports a mean 87-minute Tmax delay and a 45% lower Cmax with a high-fat meal while AUC is not affected, demonstrating that the active ingredient alone does not determine every food-effect parameter.
The best interpretation therefore separates rate of absorption, peak exposure and integrated exposure, attaches each finding to the studied formulation and meal condition, and avoids converting PK percentages directly into clinical-outcome predictions. For the complete PK context, the sildenafil pharmacokinetics hub connects food effects with absorption, bioavailability, exposure, metabolism and elimination.
| Research Question | Sildenafil-Specific Answer |
|---|---|
| Does a high-fat meal delay conventional-tablet absorption? | Yes; mean Tmax is delayed approximately 60 minutes. |
| Does it reduce conventional-tablet Cmax? | Yes; mean Cmax is reduced approximately 29%. |
| Does it reduce conventional-tablet AUC by the same amount? | No; the dedicated 100 mg study found an approximately 11% reduction. |
| Are food effects identical across sildenafil formulations? | No; VYBRIQUE oral film has a different quantitative fed-state profile. |
| Does a PK food effect guarantee a proportional clinical change? | No. |
Current U.S. conventional-tablet labeling reports a mean Tmax delay of about 60 minutes and a mean Cmax reduction of about 29% after a high-fat meal.
In a dedicated crossover study using a 100 mg conventional sildenafil tablet, mean AUC was approximately 11% lower after a standardized high-fat meal. The effect on total exposure was therefore smaller than the approximately 29% reduction in Cmax.
In the 100 mg tablet crossover study, mean Tmax was approximately 0.95 hour fasting and 2.04 hours after the high-fat meal.
No. Current VYBRIQUE oral-film labeling reports a mean Tmax delay of 87 minutes and a 45% reduction in Cmax after a high-fat meal, while AUC was not affected by food. Food-effect results should therefore be tied to the specific formulation studied.
No. Tmax measures the timing of peak plasma concentration, not the exact onset of pharmacodynamic response. Current tablet labeling notes that sildenafil may take somewhat longer to start working after a high-fat meal, but an exact one-hour onset delay is not established for every individual.
Food-effect pharmacokinetic percentages do not provide a formula for changing a sildenafil dose. Dose selection belongs to the applicable product labeling and clinical prescribing context.